{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:03:49Z","timestamp":1791813829572,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12886-015-0166-0","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T11:10:08Z","timestamp":1450091408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series"],"prefix":"10.1186","volume":"15","author":[{"given":"Dominik","family":"Bleisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"166_CR1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO, Beiser JA, Brandt JD, Heuer DH,\u00a0Higginbotham EJ,\u00a0Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714\u201320. discussion 829\u201330.","journal-title":"Arch Ophthalmol"},{"key":"166_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","volume":"116","author":"DC Musch","year":"2009","unstructured":"Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK, Investigators CS. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200\u20137.","journal-title":"Ophthalmology"},{"key":"166_CR3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","volume":"114","author":"MC Leske","year":"2007","unstructured":"Leske MC, Heijl A, Hyman L,\u00a0Bengtsson B,\u00a0Dong L,\u00a0Yang Z, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965\u201372.","journal-title":"Ophthalmology"},{"key":"166_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The Advanced Glaucoma Intervention Study (AGIS): 7","year":"2000","unstructured":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130:429\u201340.","journal-title":"Am J Ophthalmol"},{"key":"166_CR5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ,\u00a0Johnson CA,\u00a0Keltner JL,\u00a0Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313. discussion 829\u201330.","journal-title":"Arch Ophthalmol"},{"key":"166_CR6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bjo.87.10.1252","volume":"87","author":"CC Murphy","year":"2003","unstructured":"Murphy CC, Burnett CA, Spry PG, Broadway DC, Diamond JP. A two centre study of the dose\u2013response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003;87:1252\u20137.","journal-title":"Br J Ophthalmol"},{"key":"166_CR7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/bjo.2007.116533","volume":"91","author":"ME Iliev","year":"2007","unstructured":"Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2007;91:1631\u20135.","journal-title":"Br J Ophthalmol"},{"key":"166_CR8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00417-006-0280-z","volume":"244","author":"M Grueb","year":"2006","unstructured":"Grueb M, Rohrbach JM, Bartz-Schmidt KU, Schlote T. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2006;244:1293\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"166_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1442-9071.2006.01241.x","volume":"34","author":"SA Vernon","year":"2006","unstructured":"Vernon SA, Koppens JM, Menon GJ, Negi AK. Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. Clin Experiment Ophthalmol. 2006;34:411\u201320.","journal-title":"Clin Experiment Ophthalmol"},{"key":"166_CR10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bjo.2008.145565","volume":"94","author":"AP Rotchford","year":"2010","unstructured":"Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94:1180\u20133.","journal-title":"Br J Ophthalmol"},{"key":"166_CR11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","volume":"91","author":"A Heijl","year":"2013","unstructured":"Heijl A, Buchholz P, Norrgren G, Bengtsson B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. 2013;91:406\u201312.","journal-title":"Acta Ophthalmol"},{"key":"166_CR12","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","volume":"55","author":"BC Chauhan","year":"2014","unstructured":"Chauhan BC, Malik R, Shuba LM, Rafuse PE, Nicolela MT, Artes PH. Rates of glaucomatous visual field change in a large clinical population. Invest Ophthalmol Vis Sci. 2014;55:4135\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"166_CR13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1167\/iovs.09-3806","volume":"51","author":"KG Ahrlich","year":"2010","unstructured":"Ahrlich KG, De Moraes CG, Teng CC,\u00a0Prata TS,\u00a0Tello C,\u00a0Ritch R, et al. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. Invest Ophthalmol Vis Sci. 2010;51:1458\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"166_CR14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archophthalmol.2011.72","volume":"129","author":"CG Moraes De","year":"2011","unstructured":"De Moraes CG, Juthani VJ, Liebmann JM,\u00a0Teng CC,\u00a0Tello C,\u00a0Susanna R, et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129:562\u20138.","journal-title":"Arch Ophthalmol"},{"key":"166_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/aos.12073","volume":"92","author":"V Bertrand","year":"2014","unstructured":"Bertrand V, Fieuws S, Stalmans I, Zeyen T. Rates of visual field loss before and after trabeculectomy. Acta Ophthalmol. 2014;92:116\u201320.","journal-title":"Acta Ophthalmol"},{"key":"166_CR16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajo.2009.09.010","volume":"149","author":"FA Folgar","year":"2010","unstructured":"Folgar FA, de Moraes CG, Prata TS,\u00a0Teng CC,\u00a0Tello C,\u00a0Ritch R, et al. Glaucoma surgery decreases the rates of localized and global visual field progression. Am J Ophthalmol. 2010;149:258\u201364. e2.","journal-title":"Am J Ophthalmol"},{"key":"166_CR17","unstructured":"World Glaucoma Association (WGA). Guidelines on Design and Reporting of Glaucoma Surgical Trials. Available at www.worldglaucoma.org (accessed on September 3, 2015)."},{"key":"166_CR18","volume-title":"Linear Mixed Models for Longitudinal Data","author":"G Verbeke","year":"2000","unstructured":"Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer-Verlag; 2000."},{"key":"166_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","volume":"92","author":"BC Chauhan","year":"2008","unstructured":"Chauhan BC, Garway-Heath DF, Go\u00f1i FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569\u201373.","journal-title":"Br J Ophthalmol"},{"key":"166_CR20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","volume":"116","author":"A Heijl","year":"2009","unstructured":"Heijl A, Bengtsson B, Hyman L, Leske MC, Group EMGT. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271\u20136.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-015-0166-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T01:33:01Z","timestamp":1498267981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2415\/15\/179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1186\/s12886-015-0166-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"179"}}